Patents by Inventor Michael Reardon

Michael Reardon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of preparing cytotoxic benzodiazepine derivatives
    Patent number: 11981688
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: May 14, 2024
    Assignee: IMMUNOGEN, INC.
    Inventors: Michael Reardon, Richard A. Silva
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20230286914
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: January 19, 2023
    Publication date: September 14, 2023
    Inventors: Michael Reardon, Richard A. Silva
  • Methods of preparing cytotoxic benzodiazepine derivatives
    Patent number: 11591296
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: February 28, 2023
    Assignee: IMMUNOGEN, INC.
    Inventors: Michael Reardon, Richard A. Silva
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20230045079
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: June 15, 2022
    Publication date: February 9, 2023
    Inventors: Michael Reardon, Richard A. Silva
  • Methods of preparing cytotoxic benzodiazepine derivatives
    Patent number: 11396519
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: July 26, 2022
    Assignee: IMMUNOGEN, INC.
    Inventors: Michael Reardon, Richard A. Silva
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20210230114
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: January 7, 2021
    Publication date: July 29, 2021
    Inventors: Michael Reardon, Richard A. Silva
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20210122768
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 29, 2021
    Inventors: Michael Reardon, Richard A. Silva
  • Method of preparing glucosylceramide synthase inhibitors
    Patent number: 10954230
    Abstract: This invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 23, 2021
    Assignee: GENZYME CORPORATION
    Inventors: Craig S. Siegel, Rayomand Gimi, Michael Reardon, Jin Zhao
  • Methods of preparing cytotoxic benzodiazepine derivatives
    Patent number: 10913713
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: February 9, 2021
    Assignee: IMMUNOGEN, INC.
    Inventors: Michael Reardon, Richard A. Silva
  • Methods of preparing cytotoxic benzodiazepine derivatives
    Patent number: 10851117
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: December 1, 2020
    Assignee: IMMUNOGEN, INC.
    Inventors: Michael Reardon, Richard A. Silva
  • METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
    Publication number: 20200181137
    Abstract: This invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Craig S. SIEGEL, Rayomand GIMI, Michael REARDON, Jin ZHAO
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20200172481
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: November 11, 2019
    Publication date: June 4, 2020
    Inventors: Michael Reardon, Richard A. Silva
  • METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
    Publication number: 20200172555
    Abstract: The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
    Type: Application
    Filed: November 11, 2019
    Publication date: June 4, 2020
    Inventors: Michael Reardon, Richard A. Silva
  • Method of preparing glucosylceramide synthase inhibitors
    Patent number: 10604518
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: March 31, 2020
    Assignee: GENZYME CORPORATION
    Inventors: Craig S. Siegel, Rayomand Gimi, Michael Reardon, Jin Zhao
  • METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
    Publication number: 20190031652
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 1, 2018
    Publication date: January 31, 2019
    Applicant: Genzyme Corporation
    Inventors: Craig S. Siegel, Rayomand Gimi, Michael Reardon, Jin Zhao
  • Method of preparing glucosylceramide synthase inhibitors
    Patent number: 10065949
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: September 4, 2018
    Assignee: GENZYME CORPORATION
    Inventors: Craig S. Siegel, Rayomand Gimi, Michael Reardon, Jin Zhao
  • METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
    Publication number: 20170334903
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: May 12, 2017
    Publication date: November 23, 2017
    Applicant: Genzyme Corporation
    Inventors: Craig S. SIEGEL, Rayomand GIMI, Michael REARDON, Jin ZHAO
  • Method of preparing glucosylceramide synthase inhibitors
    Patent number: 9682975
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: June 20, 2017
    Assignee: Genzyme Corporation
    Inventors: Craig S. Siegel, Rayomand Gimi, Michael Reardon, Jin Zhao
  • METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
    Publication number: 20160039806
    Abstract: The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 11, 2016
    Inventors: Craig S. SIEGEL, Rayomand GIMI, Michael REARDON, Jin ZHAO
  • Bath mat
    Patent number: D850151
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: June 4, 2019
    Assignee: Bath Haven Holdings LLC
    Inventor: Michael Reardon